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Abstract
Cyclophilin A (CypA) is a typical member of the cyclophilin family of peptidyl-prolyl isomerases and is involved in the
replication of several viruses. Previous studies indicate that CypA interacts with influenza virus M1 protein and impairs the
early stage of the viral replication. To further understand the molecular mechanism by which CypA impairs influenza virus
replication, a 293T cell line depleted for endogenous CypA was established. The results indicated that CypA inhibited the
initiation of virus replication. In addition, the infectivity of influenza virus increased in the absence of CypA. Further studies
indicated that CypA had no effect on the stages of virus genome replication or transcription and also did not impair the
nuclear export of the viral mRNA. However, CypA decreased the viral protein level. Additional studies indicated that CypA
enhanced the degradation of M1 through the ubiquitin/proteasome-dependent pathway. Our results suggest that CypA
restricts influenza virus replication through accelerating degradation of the M1 protein.
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Introduction
Influenza virus is an enveloped negative-sense RNA virus that
causes major public health problems worldwide. The matrix
protein (M1) is the most abundant protein in the viral particle and
forms the bridge between the viral envelope and the core. M1
protein is a multifunctional protein in the influenza virus life cycle
including uncoating, transcription, the nuclear export of vRNP,
assembly and budding. Several host cell factors have been
determined possibly to be required for regulation of influenza
virus replication through interacting with M1 at different stages of
infection [1,2,3,4]. In the previous study, Cyclophilin A (CypA)
was identified to interact with influenza virus M1 protein and
impair the early stage of the viral replication [5]. In the present
study, CypA might regulate the viral protein stability at the post-
translation level of influenza virus life cycle.
Post-translational modification of proteins by ubiquitin is a key
regulatory event in many cellular activities, such as signal
transduction, transcription, nuclear transport, membrane protein
trafficking, autophagy, and immune responses [6]. Previous studies
suggest an important involvement of the ubiquitin proteasome
system (UPS) in the influenza virus infection. For example, the
ubiquitin-vacuolar protein sorting system is required during entry
of influenza virus into cells [7]. Further studies indicate that
inhibition of the UPS affects influenza virus infection at a post-
fusion step [8]. Influenza virus inhibits host interferon response
through NS1 targeting the ubiquitin ligase TRIM25 [9]. Influenza
A virus RNA replication was regulated through the ubiquitination
and deubiquitination of NP protein [10]. However, the ubiquiti-
nation of influenza A virus M1 protein is still unknown.
CypA is a member of the immunophilin superfamily that has
peptidyl-prolyl cis-trans isomerase activity. Several lines of
evidence implicate that CypA can aid protein folding due to its
isomerase activity, and it is also active in cell signaling
[11,12,13,14]. In addition, CypA is involved in the life cycles of
several viruses, such as human immunodeficiency virus type 1
(HIV-1), influenza virus, vesicular stomatitis virus (VSV), vaccinia
virus (VV), hepatitis C virus (HCV) and hepatitis B virus (HBV)
[5,15,16,17,18,19,20,21]. Another member of the immunophilin
superfamily, Pin1, has been reported to be involved in the UPS.
Pin1 stabilizes the human T-cell leukemia virus type 1 (HTLV-1)
Tax oncoprotein and promotes malignant transformation [22].
Pin1 regulates NF-kB signaling through the UPS [23]. In the
reports related to influenza virus, CypA was shown to be in the
core of the influenza virion [24] and was up-regulated upon
infection by avian H9N2 influenza virus in a human gastric
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chicken CypA specifically interacted with the M1 protein and
suppressed the viral replication. In addition, the isomerase activity
of CypA is not necessary for viral replication [5,26], but the precise
functions and roles of CypA in the influenza virus life cycle have
not yet been elucidated. Thus, it is of interest to further understand
how CypA participates in viral replication.
A cell line depleted of endogenous CypA would be a useful
model to understand the precise functions of CypA in the
influenza virus life cycle. Therefore, in the present study, a stable
RNAi 293T cell line with maximally decreased CypA expression
(293T/CypA2) was established as described in [27]. The
replication of influenza A virus in the 293T/CypA2 and 293T
(i.e., 293T/CypA+) cell lines was characterized to further
determine the effects of CypA on virus replication. The present
data indicated that CypA inhibited influenza virus replication
through accelerating degradation of the M1 protein.
Results
CypA inhibited influenza A virus replication
To better evaluate the function of CypA during viral infection, a
293T cell line depleted of CypA expression (293T/CypA2) was
established as described in the materials and methods. Several
clonal populations of GFP-expressing cells were obtained and
analyzed for CypA depletion by characterizing the relative
amounts of CypA and cyclophilin E (CypE). The expression level
of CypA in the 293T/CypA2 cell line was not detectable by
western blotting, but the amount of CypE protein (another
member of the Cyp family) in both cell lines was similar, as shown
in Figure 1. In addition, except for the expression level of CypA,
no significant differences in cell morphology and cell cycle were
observed between the two cell lines (data not shown). We then
examined the intracellular distribution patterns of the M1 and NP
proteins in A/WSN/33-infected 293T/CypA+ and 293T/
CypA2 cell lines (MOI=1) by indirect immunofluorescence
assays (Figure 2A, B). At the early stage (2 h post-infection), M1
was not yet visualized in 293T/CypA+ cells, but it could be
visualized in 293T/CypA2 cells. At 4 h post-infection, M1 was
detected to be evenly localized in the nucleus and cytoplasm of
293T/CypA+ cells and higher levels of M1 were found to be
localized in the nucleus of 293T/CypA2 cells. At the middle stage
(6 h post-infection) of infection, M1 was mainly localized in the
nucleus in both cell lines, and at 9 h post-infection, similar results
were observed in both cell lines. However, at the late stage of
infection (12 h post-infection), M1 was dispersed throughout the
entire cell in the 293T/CypA2 cell line. In contrast, M1 was
mainly distributed in the nucleus and nuclear periphery in 293T/
CypA+ cells (Figure 2A). A similar phenomenon was observed for
the location of NP (Figure 2B). At 2 h post-infection, NP was first
detected in 293T/CypA2 but not in 293T/CypA+ cells. At 6 and
9 h post-infection, NP was located in the nucleus of 293T/CypA+
cells, but in 293T/CypA2 cells, NP was found in both the nucleus
and cytoplasm. Furthermore, at 12 h post-infection, NP had
mainly translocated from the nucleus into the cytoplasm in 293T/
CypA2 cells but was still largely located in the nucleus of 293T/
CypA+ cells (Figure 2B). The differing locations of the two viral
proteins showed that influenza A virus replication appeared to be
faster in 293T/CypA2 than in 293T/CypA+ cell line.
To determine the impact of CypA on influenza virus
replication, the one-step growth curves of influenza A/WSN/33
were examined in the 293T/CypA+ and 293T/CypA2 cell lines
(Figure 2C). These cell lines were infected (MOI=5), and the
supernatant was titrated by plaque assay at every hour post
infection. Virions in the supernatant of 293T/CypA2 cells were
first detected at 6 h post-infection, but in the supernatant of 293T/
CypA+ cells, virions were not detected until 8 h post-infection.
The results indicated that the first life cycle of influenza virus in
293T/CypA2 was ,2 h shorter than in the 293T/CypA+ cell
line.
To determine the infectivity of influenza virus in both 293T/
CypA+ and 293T/CypA2 cell lines, indirect immunofluorescence
assays were performed to detect NP protein at 4 h post-infection
(MOI=1) in both cell lines (Figure 2D). An analysis of 300 cells
indicated that the percent of infected cells of the 293T/CypA+ cell
line was only 58.4% of that in the 293T/CypA2 cell line. The
results indicated that the amount of CypA affected the viral
infection. Thus, the results of both assays above indicated that host
factor CypA inhibited influenza A virus replication.
CypA regulated influenza virus replication at the
post-transcription level
To identify the exact stage of viral replication regulated by
CypA, real-time PCR assays were performed to detect M1
mRNA, vRNA, and cRNA levels upon influenza virus infection in
the 293T/CypA+ and 293T/CypA2 cell lines. The results
demonstrated that the M1 mRNA level was similar in both
293T/CypA+ and 293T/CypA2 cells (Figure 3A), and there was
no significant differences at the vRNA or cRNA level in both cell
lines (Figure 3B, C). These results suggested that CypA had no
effect on the virus genome replication and transcription of
influenza virus and instead regulated the viral life cycle at the
post-transcription level.
CypA did not impair the nuclear export of viral mRNA
As was shown, CypA did not affect the transcription and
genome replication of influenza virus. To determine if CypA has
an effect on viral mRNA nuclear export, we compared the nuclear
and cytoplasmic abundance of M1 and NP mRNA upon influenza
virus infection at 4 h post-infection in the 293T/CypA+ and
293T/CypA2 cell lines. In addition, we also rescued the
expression of CypA in the 293T/CypA2 cell line and then
Figure 1. Characterization of the 293T/CypA2 cell lines.
Western blot of total cell lysates from the 293T/CypA+ and 293T/
CypA2 cell lines. The samples were analyzed by immunoblotting with
polyclonal anti-CypA and anti-CypE antibodies. b-actin was used as a
control.
doi:10.1371/journal.pone.0031063.g001
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mRNA upon influenza virus infection. First, we determined the
CypA protein level in the 293T/CypA+, 293T/CypA2 and
‘‘CypA re-expression’’ 293T/CypA2 cell lines (Figure 4A). Then
nuclear and cytoplasmic fractions were isolated and analyzed by
Western blotting for lamin B1 and a-tubulin (Figure 4B).The
results showed that the nuclear/cytoplasmic fractions were isolated
well. Further studies indicated that the ratio of nuclear/cytoplasm
M1 mRNA was similar in all three lines (Figure 4C). In addition,
we obtained similar results for the pattern of NP mRNA
(Figure 4C). These results suggested that the presence of CypA
in the cell had no effect on the nuclear export of viral mRNA.
CypA affected the stability of the M1 protein
As demonstrated above, CypA had no effect on influenza virus
genome transcription, replication, or on the nuclear export of viral
mRNA. Thus, we investigate if CypA impairs the viral protein
level upon infection. The protein levels of M1 after infection were
detected at various time points in both cell lines (Figure 5A). At 6 h
post-infection, M1 was detected in 293T/CypA2 but not in
293T/CypA+ cells. At 8 h post-infection, the expression of M1 in
293T/CypA2 cells was 50% higher than that in 293T/CypA+
cells, and at 10 h post-infection, the M1 protein level in 293T/
CypA2 was 32% higher than in 293T/CypA+ cells. At 12 h post-
infection in 293T/CypA2 cells, the M1 protein level was only
26% greater than in 293T/CypA+ cells (Figure 5B). A similar
phenomenon was observed for the NP protein level (Figure 5C).
Thus, the above results suggested that one function of CypA was
reducing the viral proteins content and inhibiting the viral
replication at protein level.
To analyze whether CypA influences viral protein stability,
protein degradation assays were performed. First, both 293T/
CypA+ and 293T/CypA2 cell lines were transiently transfected
with pcDNA3-FLAG-M1 or pcDNA3-FLAG-NP, respectively.
Cycloheximide (CHX) was then added 24 h post-transfection.
Cells were collected at 0, 1, 2, 3, 4, 5, and 6 h post-treatment with
CHX, and western blot analyses were performed for M1 or NP
(Figure 6A, B). The quantitative analyses demonstrated that the
half-life of M1 protein in 293T/CypA+ cell was nearly 2 h but
almost 6 h in 293T/CypA2 cells (Figure 6C). This experiment
revealed that the protein stability of M1 was significantly reduced
in 293T/CypA+ compared to 293T/CypA2 cells, indicating that
CypA decreased the protein stability of M1. Meanwhile, the
protein stability of NP was similar in both 293T/CypA+ and
293T/CypA2 cells 6 h after treatment (Figure 6B, D).
There are two different pathways, proteasome- and lysosome-
dependent, that are principally responsible for protein degradation
in cells. To address which pathway mediated the degradation of
M1, we performed parallel experiments using either the protea-
some inhibitor MG-132 or the lysosome inhibitor NH4Cl.
Treatment with MG-132 significantly inhibited the degradation
of M1 in both cell lines, whereas the NH4Cl treatment did not
inhibit M1 degradation (Figure 6E). In addition, the M1 protein
Figure 2. CypA inhibited influenza A virus replication. Localization of the M1 (A) and NP (B) proteins in WSN-infected 293T/CypA+ and 293T/
CypA2 cells. 293T/CypA+ and 293T/CypA2 cells were infected with WSN at an MOI of 1. At 2, 4, 6, 9, and 12 h post-infection, cells were fixed,
permeabilized and stained with anti-M1 (green in A), anti-NP (green in B) and DAPI (blue). (Scale bars=10 mm). C: One-step growth curves of WSN in
the 293T/CypA+ and 293T/CypA2 cell lines. The cells were counted, cultivated, and infected at an MOI of 1. Quantitation of infectious progeny viral
particles generated from infected cells by standard plaque assays. Data are presented as the standard error of the mean (SEM) from six independent
experiments. The limit of detection of the plaque assays was 10 PFU/ml was shown by the straight line. D: Different infectivities of influenza virus in
the 293T/CypA+ and 293T/CypA2 cell lines. The cells were counted, cultivated, and infected (MOI=1). At 4 h post-infection, the cells were fixed and
stained for NP protein (green). The percent of green cells was calculated, and this reflected the infectivity of the influenza virus. Data are presented as
the mean plusminus standard deviation (6SD) from three independent experiments. Significant differences (P ,0.01, t-test) are indicated by two
asterisks.
doi:10.1371/journal.pone.0031063.g002
Figure 3. CypA suppressed influenza virus replication at the
post-transcription level. Relative quantitation of M1 mRNA (A), vRNA
(B), and cRNA (C) in cells infected with A/WSN/33 at different time
points post-infection. As described in the experimental procedures,
different primers were used for the cDNA synthesis of mRNA, vRNA, and
cRNA. Comparison of viral RNA levels from influenza A M1 genes in the
presence or absence of CypA. The specificities of the amplified products
were all confirmed by melting curve analysis. In all of the PCR assays,
GAPDH was used as an internal control. Data are means 6 SD of three
separate experiments.
doi:10.1371/journal.pone.0031063.g003
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controls. As shown in Figure 6F, the M1 protein level in MG-132-
treated 293T/CypA+ cells was ,5-fold greater than in DMSO-
treated 293T/CypA+ cells. Similarly, in the 293T/CypA2 cell
line, the M1 protein level in MG-132-treated cells was 2-fold
greater than the DMSO control. These results indicated that the
degradation of M1 in both cell lines occurs via the proteasome-
dependent pathway, and CypA specifically accelerates the
degradation of M1 protein through this pathway.
To further determine if CypA affects the ubiquitination status of
M1, an in vivo ubiquitination assay was performed in CypA2,
M1- and His-ubiquitin-co-expressing cell lysates. Surprisingly,
CypA decreased both the level of non-ubiquitinated M1 and the
level of poly-ubiquitinated M1 species (Figure 7). When the
proteasomal function was inhibited by MG-132, non- and poly-
ubiquitinated M1 species accumulated to higher levels than in the
control. Furthermore, CypA over-expression increased the non-
and poly-ubiquitinated M1 species.
Discussion
CypA, as an intrinsic host defense factor, regulated influenza
virus replication. These phenomena were observed including the
difference of location of viral proteins and the reduction of the
infectivity of the virus, which reflected the state of the viral
proteins. To dig the accurate mechanism of the effect of CypA in
the life cycle of influenza virus, we detected the viral RNA level,
the location of viral mRNA, the viral proteins expression and the
stability of these viral proteins. After longitudinal comparing these
results, we concluded that CypA inhibited influenza virus
replication at the post-transcription level and maybe through
accelerating the degradation of the M1 protein.
In a previous study, CypA was shown to interact with M1 and
suppressed influenza virus replication [5]. Immunocytological
assays indicated that over-expressed CypA may prevent M1
protein from entering the nucleus at 4 h post-infection [5]. Further
studies may provide another explanation of the results that CypA
accelerated the degradation of the M1 protein and so we detected
it in the infected cells a little bit late. In addition, M1 protein was
prone to degradation in the presence of CypA and then the timing
of the influenza virus replication would be delayed. Therefore, at
different time points post influenza virus infection, both M1 and
NP protein levels were lower in 293T/CypA+ than in 293T/
CypA2 infected cell lysates (Figure 5).
In the present study, we found that CypA did not affect
influenza virus transcription and virus genomes replication or the
nuclear export of the viral mRNA but influenced the viral protein
level. So we concluded that CypA inhibits influenza virus
replication at the translational level through impairing the viral
protein synthesis or post-translation level by regulating the stability
Figure 4. CypA did not impair the nuclear export of influenza virus mRNA. The 293T/CypA+, 293T/CypA2, and CypA re-expression 293T/
CypA2 cell lines were infected with A/WSN/33 (MOI=0.1). At 4 h post-infection, the CypA expression level was analyzed by western blotting using a
polyclonal anti-CypA antibody in the three cell lines. b-actin was used as a control (A). Nuclear (N) and cytoplasmic (C) components were isolated
from the various cell lines. One tenth of the components were used for Western blot by anti-a-tubulin and anti-lamin B1 (B). The rest of the
components were used for the RNA extraction and real time PCR (C). M1 and NP mRNA levels were quantified by real-time RT-PCR using gene-specific
primers. GAPDH was quantified as an internal control. Data are means 6 SD of three separate experiments.
doi:10.1371/journal.pone.0031063.g004
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degradation of M1 protein (Figure 6). But we could not rule out
the other possibility that CypA might inhibit the viral replication
through impairing the viral proteins translation. Translational
control of influenza virus is exerted at several steps in the viral life
cycle. Thus, the virus has evolved strategies to take advantage of its
requirement for cap-dependent translation initiation, as well as the
recruitment of host cell proteins to aid in the translation of viral
mRNA [28]. However, the host cell has also evolved to counteract
the virus’ mechanisms to bolster viral protein synthesis. For
example, since viral translation is dependent upon functional
eIF2a for translation initiation, viruses have developed strategies to
prevent or reverse PKR-dependent eIF2a phosphorylation [29].
Influenza virus nonstructural (NS1) protein could interfere with
dsRNA binding to PKR, thus preventing PKR dimerization and
autophosphorylation [30]. So whether or not CypA regulates
influenza viral protein translation need further study.
The amount of endogenous CypA in cells plays an important
role in many virus infections. For example, HIV-1 replication is
influenced by the host CypA expression level [31]. It has also been
reported that the higher cellular CypA content in some cells allows
HIV-1 virus replication to occur by compensating for the
decreased binding affinity of the P222A Gag mutant for CypA
[32]. Poor infectivity of HIV-1 virions, particularly in arrested
cells, is caused by disturbed uncoating under the combined action
of high CypA levels and capsid mutations [33]. Further, the
different CypA levels in HeLa and Jurkat cells may contribute to
the CypA-CA binding either stabilizing or destabilizing the HIV-1
capsid, which is associated with the efficiency of HIV-1 infection
[34]. In the present study, these phenomena which were observed
(Figure 2) demonstrated the relevance of CypA levels to influenza
virus infectivity. As previously reported, CypA is cytosolic and
found in all tissues in mammals [35]. The different contents of
CypA in different species may be related to the infectivity of
influenza virus in the host species and CypA may play critical roles
as a host restriction factor.
To our knowledge, this is the first report to show that CypA
plays an important role in viral replication through accelerating
the degradation of a viral protein. Recently, the peptidyl-prolyl
cis/trans isomerase Pin1, another member of the cyclophilin
family, was reported to stabilize the human T-cell leukemia virus
type 1 (HTLV-1) Tax oncoprotein and promote malignant
transformation [22]. This suggests that the cyclophilin family
may be involved in the regulation of viral replication at different
stages by affecting the stability of various viral proteins. Thus, it is
of interest to further study the detailed effect of the cyclophilins,
with a focus on the proteasome system upon viral replication.
As the major intracellular protein degradation pathway, the
UPS also regulates many basic cellular processes. Inhibition of the
UPS affects the replication of several viruses, As for HIV-1, TRIM
5a accelerates the degradation of cytosolic capsid protein normally
associated with productive HIV-1 entry [36]. In contrast, the
cellular TRIM 5a is degraded upon HIV-1 infection [37]. It was
also reported that the proteasome inhibitor MG-132 affected
influenza virus replication at a post fusion step [7]. This result
suggests that the UPS is necessary for the early stage of influenza
virus replication, but the detailed mechanism was not identified. In
the present study, CypA took part in the UPS to degrade M1 and
thereby inhibit the replication of influenza virus at the post-
translational level. These results suggest the struggle between virus
offense and host defense using the UPS. Further studies are needed
to identify the preferential ubiquitinaton site of M1 so that
differences among the different M1 protein subtypes can be
compared, which also could indicate the possible relationship
between different infectivity and numerous subtypes of influenza
virus.
Materials and Methods
Cell lines, virus, and antibodies
The Madin-Darby Canine Kidney (MDCK) cell line (ATCC
CCL-34), human embryonic kidney 293T [38] were maintained in
Dulbecco’s modified Eagle’s medium (GIBCO) supplemented with
10% heat-inactivated fetal bovine serum (GIBCO). Wild-type
influenza A virus strain A/WSN/33 (H1N1) was used in these
Figure 5. CypA inhibited the replication of influenza virus at
the viral protein level. The 293T/CypA+ and 293T/CypA2 cell lines
were infected with influenza A virus (MOI=0.1) and lysed in lysis buffer
at 6, 8, 10, and 12 h post-infection The samples were analyzed by
western blotting with a polyclonal anti-CypA antibody, monoclonal
anti-M1 antibody, and polyclonal anti-NP antibody; b-actin was used as
a control (A). Relative expression levels of M1 (B) and NP (C) were
calculated by quantifying the results shown in panel (A). Data are
means 6 SD of three separate experiments.
doi:10.1371/journal.pone.0031063.g005
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and NP were generated by immunization of 2-month-old female
rabbits with 250 mg purified hexahistidine-tagged CypA (His-
CypA), His-CypE, or His-NP in Freund’s complete adjuvant. The
generation of antibodies was boosted three times by immunization
with 150 mg of the protein at 2-week intervals. Mouse anti-M1
monoclonal antibody was prepared as described previously [39].
Anti-b-actin (sc-1616-R), anti-lamin B1 was purchased from Santa
Cruz Biotechnology and anti-a-tubulin was purchased from
Sigma. FITC-conjugated anti-Rabbit IgG and FITC-conjugated
anti-mouse IgG were purchased from Zhongshan Golden Bridge
Biotechnology (Beijing, China).
shRNA-based depletion of CypA in 293T cells
The pSUPER RNAi System (Oligoengine, Seattle, WA) was
used to generate a viral vector (pSR-CypA) to produce an shRNA




GTGAAAGCAGGAACCCGGG-39 [27]. The oligo duplex was
cloned into the BglII/HindIII sites of pSRgfp/neo. A stable cell line
expressing the shRNA to CypA was generated using a retroviral
spin infection. Retroviral supernatant was generated from 293T
cells transfected with the pSR-shCypA with the pCL-Eco packaging
construct and pCL-VSVG. The 293T cells were grown to sub-
confluence in a 12-well dish. Cells and viral supernatant were then
centrifuged at 2,500 rpm for 2 h at 32uC with 8 mg/ml polybrene.
Several clonal populations of GFP-expressing cells were obtained
and measured for CypA depletion. To measure CypA depletion, a
short-length (,1 kb) cDNA library was generated from total RNA
using an Aurum total RNA mini kit (Bio-RAD, Hercules, CA) and
an iScript cDNA Synthesis kit (Bio-Rad, Hercules, CA). CypA
primers, position 1–20 and position 147–166, were used for
quantitative real-time PCR. Primers targeting the CypA intron,
b-actin, and GAPDH were used as controls. Primer sequences are
available upon request. SYBR green supermix, the MyiQ single-
color PCR detection system, and optical system software (Bio-Rad)
were used for real-time PCR [40]
Indirect immunofluorescence
The 293T/CypA+ and 293T/CypA2 cells, growing on glass
cover slips, were infected with WSN at an MOI of 0.1. The cells
were then washed with PBS three times, fixed in 4% paraformal-
dehyde for 30 min at room temperature, permeabilized with 0.5%
triton X-100 in PBS (PBST) for 20 min, and stained with
appropriate antibodies. Cell nuclei were stained with 5 mg/ml
DAPI (Sigma) in PBS. Following staining, cover slips were
analyzed using an LSCMFV500 confocal microscope.
Plaque assay
MDCK cell monolayers (1.5610
6 cells at a confluency of 100%
in a 12-well chamber) were washed with PBS and infected with
different dilutions of virus for 1 h at 37uC. The virus inoculums
were removed by washing with PBS. Cell monolayers were then
overlaid with agar overlay medium (DMEM supplemented with
1% low melting point agarose and 1 mg/ml TPCK-treated trypsin)
and incubated at 37uC. Visible plaques were counted at 4 days
post-infection, and the virus titers were determined. All data are
expressed as the mean of three independent experiments.
Virus infection and infectivity assay
Equal numbers of 293T/CypA+ and 293T/CypA2 cells were
grown on cover slips in a 24-well chamber and infected with A/
WSN/33 (MOI=1). At 4 h post-infection, the cells were fixed,
and analyzed by indirect immunofluorescence using anti-NP
antibody and FITC-conjugated anti-rabbit IgG antibody.
RNA extraction and cDNA synthesis
Equal numbers of 293T/CypA+ and 293T/CypA2 cells were
cultivated and infected with WSN (MOI=0.1). Total RNA was
extracted at 0, 2, 4, 6, and 8 h post-infection using Trizol reagent
(Invitrogen). The purified RNA samples were treated with DNase
I (TaKaRa) for 30 min at 37uC. Total RNA (1.5 mg) was reverse
transcribed by AMV reverse transcriptase (Promega) according to
the protocol provided by the manufacturer and 10 pmol of cRNA-
specific primer (primer: 59-AGTAGAAACAAGG-39), 10 pmol of
Figure 6. CypA accelerated the degradation of M1 protein through the proteasome-dependent pathway. Both 293T/CypA2 and 293T/
CypA+ cell lines were transfected with pcDNA3-FLAG-M1 (A) or pcDNA3-FLAG-NP (B), respectively. Cells were then treated with CHX (100 mg/ml) 24 h
post-transfection, and these cells were lysed at different time points. The samples were analyzed by western blotting with anti-b-actin, anti-M1, anti-
NP, and anti-CypA antibodies. Relative expression levels of M1 (C) and NP (D) were quantified. Data are presented as the 6SD from three separate
experiments. (E) Protein degradation of M1 protein was blocked by the proteasome inhibitor. The 293T/CypA2 and 293T/CypA+ cell lines were
transfected with pcDNA3-FLAG-M1. CHX was then added 24 h post-transfection, and DMSO, lysosome inhibitor (NH4Cl), and proteasome inhibitor
(MG-132) were added for 8 h. The cell lysates were harvested and analyzed by western blotting with anti-M1, anti-CypA, and anti-b-actin antibodies.
The relative protein level of M1 was calculated by quantifying the results shown in panel (F). Data are presented as the 6SD from three separate
experiments.
doi:10.1371/journal.pone.0031063.g006
Figure 7. In vivo ubiquitination assay suggested that CypA
increased the ubiquitination of the M1 protein. 293T/CypA2
cells were transfected with expression constructs for Myc-tagged CypA,
FLAG-tagged full-length M1, and His-tagged ubiquitin. Forty hours
post-transfection, the proteasome inhibitor MG-132 (dissolved in
DMSO) was added to the cells for 4 h at a final concentration of
10 mM. Cell extracts were then immunoprecipitated with Ni2+-NTA
beads. The eluted proteins were analyzed by western blotting using an
anti-FLAG monoclonal antibody.
doi:10.1371/journal.pone.0031063.g007
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primer 2: 59-AGCAAAAGCAGG-39) [41], or 10 pmol of oligo-
dT primer. AMV reverse transcriptase exonuclease activity was
then heat inactivated at 95uC for 5 min. Negative controls
(amplifications in the absence of RNA or primers) were included
in parallel to ascertain absence of contamination by template
nucleic acids and the efficiency in RT inactivation. cDNA was
stored at 280uC.
Real-time PCR analysis
The analysis of the relative M1 gene expression was performed
using Corbett 6200 and PCR primers: M1 forward (59-
TCTGATCCTCTCGTCATTGCAGCAA-39) and M1 reverse
(59-AATGACCATCGTCAACATCCACAGC-39) [3]. GAPDH
served as an internal control using PCR primers: GAPDH forward
(59-GGTGGTCTCCTCTGACTTCAACA-39) and GAPDH re-
verse (59-GTTGCTGTAGCCAAATTCGTTGT-39), as de-
scribed in [42]. The cycling conditions comprised an initial
denaturation step of 30 s at 95uC, followed by 40 two-step cycles
(95uC for 5 s and 60uC for 30 s). Dissociation curve analysis was
performed after each assay to ensure specific target detection. All
data and standard deviations were determined from three
independent experiments.
Nuclear and cytoplasmic mRNA quantification by
real-time PCR
Nuclear and cytoplasmic RNA was fractionated from cells as
described in [43]. Briefly, the cells were lysed in RSB (10 mM
Tris, pH 7.4, 10 mM NaCl, 3 mM MgCl2) containing 0.5%
Nonidet P-40, 10% glycerol, and 100 units/ml rRNasin
(Promega). Nuclei were further washed with 1% Tween-40 and
0.5% sodium deoxycholate, and RNA from both cytoplasmic and
nuclear fractions was purified using Trizol (Invitrogen). The
purified RNA samples were treated with DNase I (TaKaRa) for
30 min at 37uC. One microgram of total RNA was used for cDNA
synthesis with the oligo(dT)18 primer, followed by real-time RT-
PCR quantification. Negative controls (amplifications in the
absence of RNA or primers) were included in parallel to ascertain
absence of contamination by template nucleic acids and the
efficiency in RT inactivation. The resulting relative M1 and NP
mRNA levels were normalized by the geometric mean of the
housekeeping gene (GAPDH).
Protein degradation assay
Both 293T/CypA+ and 293T/CypA2 cell lines were trans-
fected with pcDNA3-FLAG-M1 or pcDNA3-FLAG-NP plasmids.
CHX (100 mg/ml) was added to the medium 24 h post-
transfection, and the cells were harvested at different time points.
Western blots were probed with anti-b-actin, anti-M1, anti-NP,
and anti-CypA antibodies. MG-132 and NH4Cl were used at the
same time as CHX, and the cells were harvested 8 h after
treatment.
In vivo ubiquitination assays
293T/CypA2 cells were transfected with expression constructs
for Myc-CypA, FLAG-tagged full-length M1, and His-tagged
ubiquitin. Thirty-two hours post-transfection, the proteasome
inhibitor MG-132 (dissolved in DMSO) was added to the cells for
4 h at a final concentration of 10 mM. Cells from each plate were
collected into two aliquots. One aliquot (10%) was used for
conventional western blotting to confirm expression and degrada-
tion of the transfected proteins. The remaining cells (90%) were
used for purification of the His6-tagged proteins by Ni
2+-
nitrilotriacetic acid (NTA) beads. The cell pellet was lysed in
buffer A (6 M guanidinium-HCl, 0.1 M Na2HPO4/NaH2PO4,
0.01 M Tris-Cl [pH 8.0], 5 mM imidazole, and 10 mM b-
mercaptoethanol) and incubated with Ni
2+-NTA beads (Qiagen)
for 4 h at room temperature. The beads were then washed with
buffer A, buffer B (8 M urea, 0.1 M Na2PO4/NaH2PO4, 0.01 M
Tris-Cl [pH 8.0], and 10 mM b-mercaptoethanol), and buffer C
(8 M urea, 0.1 M Na2PO4/NaH2PO4, 0.01 M Tris-Cl [pH 6.3],
and 10 mM b-mercaptoethanol), and bound proteins were eluted
with buffer D (200 mM imidazole, 0.15 M Tris-Cl [pH 6.7], 30%
glycerol, 0.72 M b-mercaptoethanol, and 5% SDS). The eluted
proteins were analyzed by western blotting using an anti-FLAG
monoclonal antibody.
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